Earnings History Data for Gain Therapeutics, Inc. (GANX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Gain Therapeutics, Inc.

Gain Therapeutics Inc. is redefining drug discovery with its See-Tx(TM) target identification platform. It involved in identifying and optimizing allosteric binding sites which have never before been targeted. The company is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding. Gain Therapeutics Inc. is based in BETHESDA, Md.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
24-03-2022 PM GANX Gain Therapeutics 52.00 -0.25 -0.49 0.00 Gain Therapeutics GAAP EPS of -$1.37 beats by $0.25, revenue of $0.16M beats by $0.01M
[3/24/2022 9:29 AM]
4.50 0.08 
(1.81%)
0.0 0.0 
(0.00%)
2.98 - 17.93 47,297 55,452 0
12-11-2021 PM Before the open
(Nov 12)
GANX Gain Therapeutics 93.00 -0.39 -0.34 0.00 Gain Therapeutics EPS misses by $0.03
[11/12/2021 8:06 AM]
8.25 0.77 
(10.29%)
0.0 0.0 
(0.00%)
6.50 - 17.93 202,383 80,000 0
11-08-2021 AH GANX Gain Therapeutics, Inc. 94.00 -0.30 -0.31 0.00 Gain Therapeutics Q2 EPS in-line
[8/11/2021 5:04 PM]
7.70 -0.10 
(-1.28%)
0.0 0.0 
(0.00%)
7.61 - 17.93 21,832 20,000 0